{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T21:46:58Z","timestamp":1784238418101,"version":"3.55.0"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T00:00:00Z","timestamp":1745020800000},"content-version":"vor","delay-in-days":108,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008634","name":"University of Texas at San Antonio","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008634","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IDCases"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/j.idcr.2025.e02233","type":"journal-article","created":{"date-parts":[[2025,4,20]],"date-time":"2025-04-20T13:57:37Z","timestamp":1745157457000},"page":"e02233","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["A case of recurrent Candida glabrata fungemia and successful treatment with rezafungin"],"prefix":"10.1016","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7853-4681","authenticated-orcid":false,"given":"Divya","family":"Chandramohan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Aguilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"Gawrys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan P.","family":"Wiederhold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristi","family":"Traugott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas F.","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.idcr.2025.e02233_bib1","doi-asserted-by":"crossref","DOI":"10.1128\/cmr.00019-23","article-title":"Fungal endocarditis: pathophysiology, epidemiology, clinical presentation, diagnosis, and management","volume":"36","author":"Thompson","year":"2023","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"10.1016\/j.idcr.2025.e02233_bib2","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the infectious diseases society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.idcr.2025.e02233_bib3","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/myc.13398","article-title":"Clinical features, diagnosis and treatment outcome of fungal endocarditis: a systematic review of reported cases","volume":"65","author":"Meena","year":"2022","journal-title":"Mycoses"},{"issue":"2","key":"10.1016\/j.idcr.2025.e02233_bib4","doi-asserted-by":"crossref","DOI":"10.1111\/myc.70032","article-title":"Candida infective endocarditis in patients with Candida spp. bloodstream infection: risk factors and 1- year mortality","volume":"68","author":"Vieceli","year":"2025","journal-title":"Mycoses"},{"key":"10.1016\/j.idcr.2025.e02233_bib5","unstructured":"Lexicomp Online, Pediatric and neonatal lexi-drugs online. Waltham, MA: UpToDate, Inc.; July 30, 2021. \u3008https:\/\/online.lexi.com\u3009 [Accessed 22 May 2024]."},{"key":"10.1016\/j.idcr.2025.e02233_bib6","unstructured":"Micromedex\u00ae 2.0 (Healthcare Series), (electronic version). Truven health analytics, Greenwood Village, Colorado, USA. Available at: \u3008http:\/\/www.micromedexsolutions.com\/\u3009 [Accessed: 18 September 2021]."},{"key":"10.1016\/j.idcr.2025.e02233_bib7","unstructured":"Rezafungin. Package insert. Patheon Italia S.p.A., a Thermo Fisher Scientific company; 2023."},{"issue":"10370","key":"10.1016\/j.idcr.2025.e02233_bib8","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0140-6736(22)02324-8","article-title":"Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial","volume":"401","author":"Thompson","year":"2023","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.idcr.2025.e02233_bib9","article-title":"Treatment of Candida glabrata native valve endocarditis with rezafungin: a case report","volume":"6","author":"Mori","year":"2024","journal-title":"JAC Antimicrob Resist"},{"issue":"8","key":"10.1016\/j.idcr.2025.e02233_bib10","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00750-24","article-title":"Safety of rezafungin as a long-term treatment option in two patients with complicated fungal infections: two cases from Lecco Hospital (Italy)","volume":"68","author":"Ponta","year":"2024","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.idcr.2025.e02233_bib11","series-title":"Performance standards for antifungal susceptibility testing of yeasts: 3rd ed., CLSI supplement M27M44S","author":"Clinical Laboratory Standards Institute","year":"2022"},{"issue":"4","key":"10.1016\/j.idcr.2025.e02233_bib12","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1128\/JCM.42.4.1519-1527.2004","article-title":"Incidence of Bloodstream Infections Due to Candida Species and In Vitro Susceptibilities of Isolates Collected from 1998 to 2000 in a Population-Based Active Surveillance Program","volume":"42","author":"Hajjeh","year":"2004","journal-title":"J Clin Microbiol"},{"issue":"4","key":"10.1016\/j.idcr.2025.e02233_bib13","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1128\/JCM.02117-09","article-title":"Results from the ARTEMIS DISK global antifungal surveillance study, 1997 to 2007: a 10.5-year analysis of susceptibilities of candida species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion","volume":"48","author":"Pfaller","year":"2010","journal-title":"J Clin Microbiol"},{"issue":"SS-8","key":"10.1016\/j.idcr.2025.e02233_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss6808a1","article-title":"Population-based active surveillance for culture-confirmed candidemia \u2014 four sites, United States, 2012\u20132016","volume":"68","author":"Toda","year":"2019","journal-title":"MMWR Surveill Summ"},{"issue":"7","key":"10.1016\/j.idcr.2025.e02233_bib15","doi-asserted-by":"crossref","first-page":"a019752","DOI":"10.1101\/cshperspect.a019752","article-title":"Mechanisms of antifungal drug resistance","volume":"5","author":"Cowen","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.idcr.2025.e02233_bib16","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1128\/AAC.46.6.1773-1780.2002","article-title":"Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins","volume":"46","author":"Kuhn","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.idcr.2025.e02233_bib17","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2165\/11315610-000000000-00000","article-title":"Clinical aspects of invasive candidiasis","volume":"69","author":"Venditti","year":"2009","journal-title":"Drugs"}],"container-title":["IDCases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214250925000885?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214250925000885?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T11:24:07Z","timestamp":1749554647000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214250925000885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":17,"alternative-id":["S2214250925000885"],"URL":"https:\/\/doi.org\/10.1016\/j.idcr.2025.e02233","relation":{},"ISSN":["2214-2509"],"issn-type":[{"value":"2214-2509","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A case of recurrent Candida glabrata fungemia and successful treatment with rezafungin","name":"articletitle","label":"Article Title"},{"value":"IDCases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idcr.2025.e02233","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e02233"}}